Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hubbard, R. C.
Right arrow Articles by Dhadda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbard, R. C.
Right arrow Articles by Dhadda, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2003, Vol. 90, No. 2 166-172
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia


Clinical Investigations

Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia

R. C. Hubbard*,1, T. M. Naumann2, L. Traylor1 and S. Dhadda1

1 Pharmacia, 5200 Old Orchard Road, Skokie, IL 60077, USA. 2 Hessing’sche Orthopedic Clinic, Hessingstr, Augsburg, Germany

Corresponding author. E-mail: richard.c.hubbard@pharmacia.com
{dagger}Declaration of interest. The study was sponsored by Pharmacia Corporation and parecoxib sodium was provided by Pharmacia Corporation.

Background. This multicentre, double-blind, placebo-controlled study compared the opioid-sparing effectiveness and clinical safety of parecoxib sodium over 48 h, in 195 postoperative patients after routine total knee replacement surgery.

Methods. Elective total primary knee arthroplasty was performed under spinal anaesthesia, with a single dose of spinal bupivacaine 10–20 mg, and intraoperative sedation with midazolam 0.5–1.0 mg i.v., or propofol <6 mg kg–1 h–1. Patients were randomized to receive either parecoxib sodium 20 mg twice daily (bd) i.v. (n=65), parecoxib sodium 40 mg bd i.v. (n=67), or placebo (n=63) at the completion of surgery, and after 12, 24, and 36 h. Morphine (1–2 mg) was taken by patient-controlled analgesia or by bolus doses after 30 min.

Results. Patients receiving parecoxib sodium 20 mg bd and 40 mg bd consumed 15.6% and 27.8% less morphine at 24 h than patients taking placebo (both P<0.05). Both doses of parecoxib sodium administered with morphine provided significantly greater pain relief than morphine alone from 6 h (P<0.05). A global evaluation of study medication demonstrated a greater level of satisfaction among patients taking parecoxib sodium than those taking placebo. Parecoxib sodium administered in combination with morphine was well tolerated. However, a reduction in opioid-type side-effects was not demonstrated in the parecoxib sodium groups.

Conclusion. Parecoxib sodium provides opioid-sparing analgesic effects in postoperative patients.

Br J Anaesth 2003; 90: 166–72


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
S. A. Schug, G. P. Joshi, F. Camu, S. Pan, and R. Cheung
Cardiovascular Safety of the Cyclooxygenase-2 Selective Inhibitors Parecoxib and Valdecoxib in the Postoperative Setting: An Analysis of Integrated Data
Anesth. Analg., January 1, 2009; 108(1): 299 - 307.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. R. Viscusi, J. S. Gimbel, A. M. Halder, M. Snabes, M. T. Brown, and K. M. Verburg
A Multiple-Day Regimen of Parecoxib Sodium 20 mg Twice Daily Provides Pain Relief After Total Hip Arthroplasty
Anesth. Analg., August 1, 2008; 107(2): 652 - 660.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Zhang, E. L. Ding, and Y. Song
Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized Trials
JAMA, October 4, 2006; 296(13): 1619 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. Munsterhjelm, T. T. Niemi, O. Ylikorkala, P. J. Neuvonen, and P. H. Rosenberg
Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers
Br. J. Anaesth., August 1, 2006; 97(2): 226 - 231.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. P. Malan Jr, S. Gordon, R. Hubbard, and M. Snabes
The Cyclooxygenase-2-Specific Inhibitor Parecoxib Sodium Is as Effective as 12 mg of Morphine Administered Intramuscularly for Treating Pain After Gynecologic Laparotomy Surgery
Anesth. Analg., February 1, 2005; 100(2): 454 - 460.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. L. Apfelbaum, T. J. Gan, S. Zhao, D. B. Hanna, and C. Chen
Reliability and Validity of the Perioperative Opioid-Related Symptom Distress Scale
Anesth. Analg., September 1, 2004; 99(3): 699 - 709.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Kranke, A. M. Morin, N. Roewer, and L. H. Eberhart
Patients' Global Evaluation of Analgesia and Safety of Injected Parecoxib for Postoperative Pain: A Quantitative Systematic Review
Anesth. Analg., September 1, 2004; 99(3): 797 - 806.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
E. F. Ekman and L. A. Koman
Acute Pain Following Musculoskeletal Injuries and Orthopaedic Surgery. Mechanisms and Management
J. Bone Joint Surg. Am., June 1, 2004; 86(6): 1316 - 1327.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. J. Gan, G. P. Joshi, E. Viscusi, R. Y. Cheung, W. Dodge, J. G. Fort, and C. Chen
Preoperative Parenteral Parecoxib and Follow-Up Oral Valdecoxib Reduce Length of Stay and Improve Quality of Patient Recovery After Laparoscopic Cholecystectomy Surgery
Anesth. Analg., June 1, 2004; 98(6): 1665 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
P. C. Walker and D. S. Wagner
Treatment of Pain in Pediatric Patients
Journal of Pharmacy Practice, August 1, 2003; 16(4): 261 - 275.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.